Thats why clarifying the role of different medications is so vital
Nyyssonen K, et al
Some users combine them in protocols aimed at overall body composition changes, hoping for more growth hormone release, preserving lean muscle, and the ability to maintain muscle mass during fat loss phases
In SYNCHRONIZE-1, participants lost up to an average of 39.2 lb (17.8 kg) from baseline after 76 weeks of treatment with survodutide, a glucagon/GLP-1 receptor dual agonist 1 The trial met both weight loss primary endpoints and its key secondary endpoint evaluating waist circumference, a predictor of cardiometabolic risk, together demonstrating survodutide's potential to broadly improve metabolic health 1 In addition to these positive results, Boehringer is advancing its broad metabolic health R&D program, exploring multiple pharmaceutical approaches to weight management including oral treatments Ingelheim, Germany
Artif Organs 26:163168 Falk MC, Knight JF, Roy LP, Wilcken B, Schell DN, O'Connell AJ, Gillis J (1994) Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism